Exploring the minimal important difference in the treatment of paediatric obsessive-compulsive disorder using selective serotonin reuptake inhibitors

BMJ Ment Health. 2024 Jun 19;27(1):e300999. doi: 10.1136/bmjment-2024-300999.

Authors

Sem E Cohen^{1

2}, Damiaan A J P Denys^{3

2}, Taina Kristiina Mattila⁴, Bram W C Storosum^{3

2}, Anthonius de Boer^{4

5}, Jasper Brian Zantvoord^{3

2}

Affiliations

¹ Psychiatry, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands s.e.cohen@amsterdamumc.nl.
² Amsterdam Neuroscience, Amsterdam, The Netherlands.
³ Psychiatry, Amsterdam UMC Locatie AMC, Amsterdam, The Netherlands.
⁴ Medicines Evaluation Board, Utrecht, The Netherlands.
⁵ Emeritus Professor of Pharmacotherapy, Utrecht University, Utrecht, The Netherlands.

No abstract available

Keywords: child & adolescent psychiatry; data interpretation, statistical.

Publication types

Letter

MeSH terms

Adolescent
Child
Humans
Obsessive-Compulsive Disorder* / drug therapy
Selective Serotonin Reuptake Inhibitors* / therapeutic use

Substances

Selective Serotonin Reuptake Inhibitors